151 related articles for article (PubMed ID: 20701065)
1. Fecal cytology in conjunction with immunofecal occult blood test for colorectal cancer screening.
Sheng JQ; Li SR; Su H; Li JS; Sun ZQ; Wu ZT; Wu X; Xia CH; Rao J
Anal Quant Cytol Histol; 2010 Jun; 32(3):131-5. PubMed ID: 20701065
[TBL] [Abstract][Full Text] [Related]
2. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
[TBL] [Abstract][Full Text] [Related]
3. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients.
Li S; Wang H; Hu J; Li N; Liu Y; Wu Z; Zheng Y; Wang H; Wu K; Ye H; Rao J
Int J Cancer; 2006 Jun; 118(12):3078-83. PubMed ID: 16425283
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer screening: comparison of transferrin and immuno fecal occult blood test.
Chen JG; Cai J; Wu HL; Xu H; Zhang YX; Chen C; Wang Q; Xu J; Yuan XL
World J Gastroenterol; 2012 Jun; 18(21):2682-8. PubMed ID: 22690078
[TBL] [Abstract][Full Text] [Related]
5. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening.
van Rossum LG; van Rijn AF; van Oijen MG; Fockens P; Laheij RJ; Verbeek AL; Jansen JB; Dekker E
Int J Cancer; 2009 Aug; 125(4):746-50. PubMed ID: 19408302
[TBL] [Abstract][Full Text] [Related]
6. A simplified, non-invasive fecal-based DNA integrity assay and iFOBT for colorectal cancer detection.
Kalimutho M; Del Vecchio Blanco G; Cretella M; Mannisi E; Sileri P; Formosa A; Pallone F; Federici G; Bernardini S
Int J Colorectal Dis; 2011 May; 26(5):583-92. PubMed ID: 21225430
[TBL] [Abstract][Full Text] [Related]
7. The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test.
Kim YC; Kim JH; Cheung DY; Kim TH; Jun EJ; Oh JW; Kim CW; Chung WC; Kim BW; Kim SS; Kim JI; Park SH; Kim JK
Gut Liver; 2015 Sep; 9(5):641-8. PubMed ID: 25473070
[TBL] [Abstract][Full Text] [Related]
8. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
9. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
Lohsiriwat V; Thavichaigarn P; Awapittaya B
J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
[TBL] [Abstract][Full Text] [Related]
10. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
[TBL] [Abstract][Full Text] [Related]
11. [Comparison between application of fecal occult blood quantitive testing instrument and colloidal gold strip method in colorectal cancer screening].
Huang YQ; Zhang MW; Shen YZ; Ma HQ; Cai SR; Zhang SZ; Zheng S
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):747-51. PubMed ID: 24246083
[TBL] [Abstract][Full Text] [Related]
12. Fecal Occult Blood Tests in Colorectal Cancer Screening: Systematic Review and Meta-analysis of Traditional and New-generation Fecal Immunochemical Tests.
Meklin J; SyrjÄnen K; Eskelinen M
Anticancer Res; 2020 Jul; 40(7):3591-3604. PubMed ID: 32620599
[TBL] [Abstract][Full Text] [Related]
13. Transferrin dipstick as a potential novel test for colon cancer screening: a comparative study with immuno fecal occult blood test.
Sheng JQ; Li SR; Wu ZT; Xia CH; Wu X; Chen J; Rao J
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2182-5. PubMed ID: 19661074
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of a new immunochemical fecal occult blood test in Korean patients referred for colonoscopy.
Woo HY; Mok RS; Park YN; Park DI; Sung IK; Sohn CI; Park H
Clin Biochem; 2005 Apr; 38(4):395-9. PubMed ID: 15766742
[TBL] [Abstract][Full Text] [Related]
15. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
Calistri D; Rengucci C; Casadei Gardini A; Frassineti GL; Scarpi E; Zoli W; Falcini F; Silvestrini R; Amadori D
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2647-54. PubMed ID: 20929882
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the sensitivity of an immunochemical fecal occult blood test for colorectal neoplasia.
Yoshinaga M; Motomura S; Takeda H; Yanagisawa Z; Ikeda K
Am J Gastroenterol; 1995 Jul; 90(7):1076-9. PubMed ID: 7611200
[TBL] [Abstract][Full Text] [Related]
17. [The effect of immunofecal occult blood test on colorectal cancer screening].
Yang HY; Ge ZZ; Dai J; Li XB; Gao YJ
Zhonghua Nei Ke Za Zhi; 2008 Aug; 47(8):642-5. PubMed ID: 19080296
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of the immunofecal occult blood test for colorectal cancer screening in a large population.
Yang H; Ge Z; Dai J; Li X; Gao Y
Dig Dis Sci; 2011 Jan; 56(1):203-7. PubMed ID: 20458621
[TBL] [Abstract][Full Text] [Related]
19. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of colorectal diseases in immunological fecal occult blood test (I-FOBT) positive patients in a tertiary care hospital in Bangladesh.
Mollick SH; Roy PK; Bhuiyan MR; Mia AR; Alam MS; Mollick KA; Pervin S; Hassan MQ
Mymensingh Med J; 2014 Oct; 23(4):764-9. PubMed ID: 25481598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
